BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7729951)

  • 21. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.
    Meijer L; Borgne A; Mulner O; Chong JP; Blow JJ; Inagaki N; Inagaki M; Delcros JG; Moulinoux JP
    Eur J Biochem; 1997 Jan; 243(1-2):527-36. PubMed ID: 9030781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unusual regulation of cyclin D1 and cyclin-dependent kinases cdk2 and cdk4 during in vivo mitotic stimulation of olfactory neuron progenitors in adult mouse.
    Kastner A; Moyse E; Bauer S; Jourdan F; Brun G
    J Neurochem; 2000 Jun; 74(6):2343-9. PubMed ID: 10820194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fludarabine-induced apoptosis of B chronic lymphocytic leukemia cells includes early cleavage of p27kip1 by caspases.
    Sanhes L; Tang R; Delmer A; DeCaprio JA; Ajchenbaum-Cymbalista F
    Leukemia; 2003 Jun; 17(6):1104-11. PubMed ID: 12764376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potent inhibitors of cyclin-dependent kinase 2 induce nuclear accumulation of wild-type p53 and nucleolar fragmentation in human untransformed and tumor-derived cells.
    David-Pfeuty T
    Oncogene; 1999 Dec; 18(52):7409-22. PubMed ID: 10602500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Behavior of the cell cycle-associated proteins in an unusual G0-arrestable cancer cell line.
    Ohta T; Fukuda M; Wanebo HJ; Jogo K; Yamaguchi S
    Exp Cell Res; 1996 May; 225(1):85-92. PubMed ID: 8635520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of cyclin A and p27 in anti-IgM induced G1 growth arrest of murine B-cell lymphomas.
    Ezhevsky SA; Toyoshima H; Hunter T; Scott DW
    Mol Biol Cell; 1996 Apr; 7(4):553-64. PubMed ID: 8730099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuronal cdc2-like kinase: a cdc2-related protein kinase with predominantly neuronal expression.
    Hellmich MR; Pant HC; Wada E; Battey JF
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10867-71. PubMed ID: 1279696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate.
    Liang YC; Lin-Shiau SY; Chen CF; Lin JK
    J Cell Biochem; 1999 Oct; 75(1):1-12. PubMed ID: 10462699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. S and G2 phase roles for Cdk2 revealed by inducible expression of a dominant-negative mutant in human cells.
    Hu B; Mitra J; van den Heuvel S; Enders GH
    Mol Cell Biol; 2001 Apr; 21(8):2755-66. PubMed ID: 11283255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Androgen receptor regulation of G1 cyclin and cyclin-dependent kinase function in the CWR22 human prostate cancer xenograft.
    Gregory CW; Johnson RT; Presnell SC; Mohler JL; French FS
    J Androl; 2001; 22(4):537-48. PubMed ID: 11451350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucocorticoid regulation of G1 cyclin-dependent kinase genes in lymphoid cells.
    Rhee K; Reisman D; Bresnahan W; Thompson EA
    Cell Growth Differ; 1995 Jun; 6(6):691-8. PubMed ID: 7669723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of a growth-inhibiting tripeptide, acetylGlu-Ser-GlyNH2 (Ac-ESG), on gene expression and cell cycle progression of two lymphoma cell lines.
    Liu Y; Reichelt WH; Luna L; Elgjo K; Reichelt KL
    Anticancer Res; 2003; 23(4):3159-65. PubMed ID: 12926049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human Speedy: a novel cell cycle regulator that enhances proliferation through activation of Cdk2.
    Porter LA; Dellinger RW; Tynan JA; Barnes EA; Kong M; Lenormand JL; Donoghue DJ
    J Cell Biol; 2002 Apr; 157(3):357-66. PubMed ID: 11980914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Up-regulation of cyclin-dependent kinase 4/cyclin D2 expression but down-regulation of cyclin-dependent kinase 2/cyclin E in testicular germ cell tumors.
    Schmidt BA; Rose A; Steinhoff C; Strohmeyer T; Hartmann M; Ackermann R
    Cancer Res; 2001 May; 61(10):4214-21. PubMed ID: 11358847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inducible expression of cyclin D1 in T-47D human breast cancer cells is sufficient for Cdk2 activation and pRB hyperphosphorylation.
    Musgrove EA; Sarcevic B; Sutherland RL
    J Cell Biochem; 1996 Mar; 60(3):363-78. PubMed ID: 8867812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression and subcellular localization of CDK2 and cdc2 kinases and their common partner cyclin A in thyroid epithelial cells: comparison of cyclic AMP-dependent and -independent cell cycles.
    Baptist M; Lamy F; Gannon J; Hunt T; Dumont JE; Roger PP
    J Cell Physiol; 1996 Feb; 166(2):256-73. PubMed ID: 8591985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p21waf1 can block cells at two points in the cell cycle, but does not interfere with processive DNA-replication or stress-activated kinases.
    Medema RH; Klompmaker R; Smits VA; Rijksen G
    Oncogene; 1998 Jan; 16(4):431-41. PubMed ID: 9484832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retinoic acid-mediated growth arrest of EBV-immortalized B lymphocytes is associated with multiple changes in G1 regulatory proteins: p27Kip1 up-regulation is a relevant early event.
    Zancai P; Cariati R; Rizzo S; Boiocchi M; Dolcetti R
    Oncogene; 1998 Oct; 17(14):1827-36. PubMed ID: 9778049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential regulation of p34cdc2 and p33cdk2 by transforming growth factor-beta 1 in murine mammary epithelial cells.
    Fautsch MP; Eblen ST; Anders RA; Burnette RJ; Leof EB
    J Cell Biochem; 1995 Aug; 58(4):517-26. PubMed ID: 7593274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of G1 phase regulators in MG-63 osteosarcoma cell line.
    Merli M; Benassi MS; Gamberi G; Ragazzini P; Sollazzo MR; Molendini L; Magagnoli G; Ferrari C; Maltarello MC; Picci P
    Int J Oncol; 1999 Jun; 14(6):1117-21. PubMed ID: 10339667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.